학술논문

Nuclear imaging in the new ESC Guidelines: the age of maturity.
Document Type
Article
Source
European Journal of Nuclear Medicine & Molecular Imaging. Mar2024, Vol. 51 Issue 4, p938-941. 4p.
Subject
*CARDIAC magnetic resonance imaging
*PROSTHETIC heart valves
*POSITRON emission tomography
Language
ISSN
1619-7070
Abstract
The 2023 ESC Guidelines for the management of infective endocarditis (IE) and cardiomyopathies emphasize the importance of a multidisciplinary approach and non-invasive imaging techniques. Nuclear and molecular imaging have been recognized as crucial for the diagnostic phase and subsequent clinical management. The guidelines recommend the use of different imaging modalities, such as echocardiography, CT, PET/CT, and WBC SPECT/CT, to confirm the diagnosis of IE and assess complications. For cardiomyopathies, non-invasive imaging techniques like ultrasound, cardiac magnetic resonance imaging (CMR), CT, and nuclear techniques (such as [18F]FDG PET/CT and bone scintigraphy) are essential for diagnosis and follow-up. The guidelines also highlight the role of nuclear imaging in diagnosing cardiac amyloidosis and active cardiac sarcoidosis. Overall, nuclear medicine plays a significant role in cardiac imaging and is recognized in international clinical guidelines. [Extracted from the article]